Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Abbott Stops Using ‘#1 Infant Formula Brand’ Claim After Finding Supporting Data Out Of Date
Claiming Top Brand Among Formulas In US Remains Contentious Advertising Issue
Jun 29 2023
•
By
Malcolm Spicer
Mead Johnson continues using a claim of “#1 recommended brand” variety on its Enfamil formula line, left, while Abbott is voluntarily removing a similar claim from its Similac line, right. • Source: Shutterstock/HBW Insight
More from International
More from Geography